Autoantibody Diagnostics in Autoimmune Liver Diseases

ORGENTEC Diagnostika (www.orgentec.com) has developed four new laboratory tests for the diagnosis of autoimmune liver diseases. They are based on ELISA technology and were specifically developed for fully automated analysis with Alegria®.
 
 
Spread the Word
Listed Under

Tags:
* Autoimmunity

Industrys:
* Medical
* Health

Location:
* Mainz - Rheinland-Pfalz - Germany

Subject:
* Products

Feb. 28, 2012 - PRLog -- The new tests systems, called Anti-Sp100, Anti-gp210, Anti-LKM-1, and Anti-SLA, reliably detect specific autoantibodies that are characteristic of various autoimmune liver diseases. The tests thus also allow for reliable differentiation between these autoimmune diseases and other diseases of the liver, such as viral infections, based on blood samples.

Autoimmune liver diseases are caused by a malfunctioning immune system. This category of diseases includes autoimmune hepatitis (AIH), primary biliary cirrhosis (PBC), and primary sclerosing cholangitis (PSC). As it is mostly the case, these diseases are treatable if they are detected early; if left untreated, they can lead to severe symptoms and considerable damage to the liver.

If a physician is dealing with ambiguous symptoms or needs to clarify unusual blood values, the detection of characteristic autoantibodies provides a clear indicator of autoimmune liver diseases. For instance, if Sp100 or gp210 antibodies are detected, it is most likely a case of primary biliary cirrhosis. Antibodies against LKM-1 or SLA are indicative of autoimmune hepatitis.

The triggers of autoimmune liver disease are largely unknown. They may be caused by previous or on-going infections. It is also possible that genetic predisposition may favour the development of these disorders.

For the first time, these newly introduced laboratory tests, Anti-SP100, Anti-gp210, Anti-LKM-1, and Anti-SLA, allow for the individualised, rapid, and fully automated detection of the corresponding autoantibodies. They are suitable for cost-efficient differential diagnostics or for the differentiation of positive screening results from other ELISA, immunoblot tests or immunofluorescence assays. – www.orgentec.com

# # #

Based in Mainz, ORGENTEC Diagnostika is a global leader in the development and marketing of test systems for autoimmune diagnostics and serological tests for infectious disease. ORGENTEC has developed numerous highly specific ELISA test systems, immunoblot and immunofluorescence tests, the Alegria® random access analyser, and the rheumachec® rapid test. – www.orgentec.com
End
Source:
Email:***@orgentec.com Email Verified
Phone:+49 6131 9258-0
Zip:55129
Account Email Address Verified     Disclaimer     Report Abuse
ORGENTEC Diagnostika GmbH News
Trending
Daily News
Weekly News



Like PRLog?
9K2K1K
Click to Share